TFF Pharmaceuticals Inc (TFFP): Well. That was interesting

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	7
Posts	889
Boards Moderated	0
Alias Born	06/15/2015

derkampfer

Re: None

Thursday, 02/23/2023 2:10:27 AM

Thursday, February 23, 2023 2:10:27 AM

Well. That was interesting

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent TFFP News

Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 11:07:58 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:06:12 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:29 AM
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/08/2023 09:52:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:10:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/04/2023 10:28:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:26:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 10:14:35 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/21/2023 09:41:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 09:06:38 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/04/2023 08:07:53 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/04/2023 08:07:04 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/22/2023 08:16:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 09:20:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:10:47 PM
TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option • GlobeNewswire Inc. • 08/17/2023 08:01:00 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/16/2023 08:43:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 12:00:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 12:00:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 10:11:01 AM
TFF Pharmaceuticals Prices $5 Million Public Offering of Common Stock • GlobeNewswire Inc. • 08/15/2023 10:00:00 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/14/2023 08:12:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:11:07 PM

More TFFP News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover